From Michael Scally : "Newly" found elevated BP after administering AAS can be a challenge to the user as well as the caretaker. The simple idea that this problem arises from E2 is without supportive evidence. I came to this conclusion very early in treating AAS users by the fact that no amount of E2 control managed the BP. I am sure this is the experience of many AAS users.
This is further confirmed by the fact that non-aromatizable AAS can cause elevated BP. [Proviron is reported to cause an increased BP.] This observation would lead one to conclude that the AAS itself might be the source of the BP problems and lowering E2 while AAS are high will have limited success.


More...